Health
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | NEJM – nejm.org
Correspondence from The New England Journal of Medicine — Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
After emergency use of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was authorized, the observer-blinded, pivotal Coronavirus Efficacy (COVE) trial was amended on December 23, 2020, to include an open-label phase in…
Continue Reading
-
Noosa News19 hours agoYoung voices shape Sunshine Coast’s future
-
Business19 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News16 hours agoSudden death investigation, Maroochydore – Sunshine Coast
-
General23 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’